Affymax (AFFY) wins FDA panel backing of anemia drug
Tweet
Share
E-mailGet Alerts AFFY Hot Sheet
Join SI Premium – FREE
Affymax (Nasdaq: AFFY) wins FDA panel backing of anemia drug, peginesatide. The vote was 15-1-1.
Shares were halted earlier today ahead of the vote.
Shares were halted earlier today ahead of the vote.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IMAC Holdings (BACK) halted on volatility, up 38%
- European stocks mixed; Euro banking sector, Meta Platforms in the spotlight
- ByteDance Prefers TikTok Shutdown in US if Legal Options Fail - Reuters
Create E-mail Alert Related Categories
FDA, Trader Talk, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
